These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9673254)

  • 1. Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains.
    Hatano K; Pier GB
    Infect Immun; 1998 Aug; 66(8):3719-26. PubMed ID: 9673254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.
    Hatano K; Boisot S; DesJardins D; Wright DC; Brisker J; Pier GB
    Infect Immun; 1994 Sep; 62(9):3608-16. PubMed ID: 7520416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.
    Priebe GP; Brinig MM; Hatano K; Grout M; Coleman FT; Pier GB; Goldberg JB
    Infect Immun; 2002 Mar; 70(3):1507-17. PubMed ID: 11854239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
    Kamei A; Coutinho-Sledge YS; Goldberg JB; Priebe GP; Pier GB
    Infect Immun; 2011 Mar; 79(3):1289-99. PubMed ID: 21149583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.
    Pier GB; Koles NL; Meluleni G; Hatano K; Pollack M
    Infect Immun; 1994 Apr; 62(4):1137-43. PubMed ID: 8132318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
    Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB
    Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical characterization of O polysaccharides composing the alpha-D-rhamnose backbone of lipopolysaccharide of Pseudomonas syringae and classification of bacteria into serogroups O1 and O2 with monoclonal antibodies.
    Ovod V; Rudolph K; Knirel Y; Krohn K
    J Bacteriol; 1996 Nov; 178(22):6459-65. PubMed ID: 8932301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.
    Priebe GP; Meluleni GJ; Coleman FT; Goldberg JB; Pier GB
    Infect Immun; 2003 Mar; 71(3):1453-61. PubMed ID: 12595463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies as probes to examine serotype-specific and cross-reactive epitopes of lipopolysaccharides from serotypes O2, O5, and O16 of Pseudomonas aeruginosa.
    Lam JS; Handelsman MY; Chivers TR; MacDonald LA
    J Bacteriol; 1992 Apr; 174(7):2178-84. PubMed ID: 1372599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.
    Pier GB; Meluleni G; Goldberg JB
    Infect Immun; 1995 Aug; 63(8):2818-25. PubMed ID: 7542632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
    J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a
    Moustafa DA; DiGiandomenico A; Raghuram V; Schulman M; Scarff JM; Davis MR; Varga JJ; Dean CR; Goldberg JB
    Infect Immun; 2023 Dec; 91(12):e0024723. PubMed ID: 37991349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.
    DiGiandomenico A; Rao J; Goldberg JB
    Infect Immun; 2004 Dec; 72(12):7012-21. PubMed ID: 15557624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide antigens of Pseudomonas aeruginosa.
    Knirel YA
    Crit Rev Microbiol; 1990; 17(4):273-304. PubMed ID: 1698385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharide antigens of Pseudomonas aeruginosa.
    Pier GB
    Rev Infect Dis; 1988; 10 Suppl 2():S337-40. PubMed ID: 3142017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide.
    de Kievit TR; Lam JS
    J Bacteriol; 1994 Dec; 176(23):7129-39. PubMed ID: 7525538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification.
    Berche P; Véron M; Fermanian J; Daoulas-Lebourdelles F; Guégen A
    Ann Microbiol (Paris); 1979; 130(2):179-88. PubMed ID: 90473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.